390
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration

& ORCID Icon
Pages 176-182 | Received 14 Aug 2017, Accepted 04 Oct 2017, Published online: 13 Nov 2017
 

ABSTRACT

Purpose: To investigate risk factors for treatment discontinuation for neovascular age-related macular degeneration (nAMD).

Methods: Data from the Swedish Macula Register and the Skåne Healthcare Register are reported on the treatment received by 932 nAMD patients diagnosed 2013−2015. Treatment discontinuation is defined as having a termination visit or lacking a control or treatment visit during the period of 10−14 months after the diagnostic visit. The risk of treatment discontinuation during the first year is estimated using a Poisson model and a classification tree.

Results: 503 eyes (50.9%) discontinued the treatment within the first year. Patients with visual acuity below 60 ETDRS letters (20/60 Snellen) at baseline, serious comorbidities, or treated at the university hospital have a 42% (95% CI 25−61%, P < 0.001), 27% (95% CI 13−43%, P = 0.001) and 30% (95% CI 15−46%, P < 0.001) increased risk to discontinue treatment compared with similar patients. Patients on ranibizumab therapy have a 45% (95% CI 28−63%, P < 0.001) increased risk for treatment discontinuation during year 1 compared with patients on aflibercept therapy. The classification tree also shows that patients on ranibizumab therapy and those with low VA at baseline are at a higher risk of terminating treatment.

Conclusions: Almost half of the patients starting anti-VEGF therapy discontinue treatment during the first year. Patients with risk factors may require additional support to continue with the treatment. Aflibercept therapy could be an alternative to patients at risk of treatment discontinuation.

Declaration of interest

None of the authors has any proprietary interests or conflicts of interest related to this submission.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 740.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.